Enhance the operability of medical diagnostic tools.
The project was awarded the grade of "Outstanding" by the KTP Grading Panel for its achievement in meeting KTP's objectives.
Epredia was established in July 2019 as a buyout by Shandon Diagnostics from Thermo Fisher Scientific and focuses on developing precision cancer diagnostic to improve patient outcomes by providing ground-breaking technologies.
KTP Asoociate
LinkedIn
Knowledge Base Supervisor
Company Supervisor